SPY458.97-10.47 -2.23%
DIA349.02-9.01 -2.52%
IXIC15,491.66-353.57 -2.23%

Raymond James Upgrades ADMA Biologics to Strong Buy, Announces $5 Price Target

Raymond James analyst Elliot Wilbur upgrades ADMA Biologics (NASDAQ:ADMA) from Outperform to Strong Buy and announces $5 price target.

Benzinga · 11/11/2021 07:26
Raymond James analyst Elliot Wilbur upgrades ADMA Biologics (NASDAQ:ADMA) from Outperform to Strong Buy and announces $5 price target.